New product newswire: August 21, 2006

News
Article

AstraZeneca, Wilmington, Del., (800) 842-9920, has received FDA approval for Symbicort (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol. The new inhaler is indicated for long-term maintenance treatment of asthma in patients 12 years of age and older.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.